Cargando…
Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
BACKGROUND: It is an unresolved issue as to whether cost-benefit analysis (CBA) or cost-effectiveness analysis (CEA) is the preferable analytical toolkit for use in health technology assessment (HTA). The distinction between the two and an expressed preference for CEA go back at least to 1980 in the...
Autores principales: | Culyer, Anthony J., Chalkidou, Kalipso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347566/ https://www.ncbi.nlm.nih.gov/pubmed/30661640 http://dx.doi.org/10.1016/j.jval.2018.06.005 |
Ejemplares similares
-
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018) -
Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016) -
Distributional Cost-Effectiveness Analysis Comes of Age
por: Cookson, Richard, et al.
Publicado: (2021) -
Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK
por: Culyer, Anthony J., et al.
Publicado: (2021) -
Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)